US FDA issues guidance on modernizing statistical methods for clinical trials: Maryland Wednesday, January 14, 2026, 09:00 Hrs [IST] The US Food and Drug Administration today publ ...

Industrial AI deployment traditionally requires onsite ML specialists and custom models per location. Five strategies ...

Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug dis ...

Forensic evaluation relies on rigorous quantitative techniques to assess the probative value of diverse forms of evidence. Modern forensic science increasingly integrates statistical ...

For financial institutions, threat modeling must shift away from diagrams focused purely on code to a life cycle view ...

Last week at CES, Lego introduced its new Smart Play system, with a tech-packed Smart Brick that can recognize and interact ...

Ohio legislators are rolling out legislation they say will crack down on fraud in the state’s day care system amid swirling ...

There are very good reasons declines in NAEP scores aren't correlated with performance on college admissions tests.

The FDA’s new draft guidance on Bayesian methodology signals a shift toward more flexible, data-driven clinical trial designs, enabling sponsors to use prior data and adaptive approaches to improve ...

Inflation cooled for a second straight month in December as the headline figure for the Consumer Price Index came in at 2.68% ...

Advanced Micro Devices is rapidly gaining share in the AI accelerator market, with 2024 data center revenue nearly doubling. See why AMD stock is a Buy now.

With AI Software Integrity Builder, Keysight empowers engineering teams to move from fragmented testing to a unified AI ...